![Akums Drugs, Gold Plus Glass, Ceigall, Orient Tech get SEBI nod to launch IPO](https://images.assettype.com/fortuneindia%2F2022-09%2F8e934079-db4d-4f2c-8c28-212973977238%2FSEBI_09112_copy.jpg?rect=0,184,2700,1350&w=300&q=95)
Akums Drugs, Gold Plus Glass, Ceigall, Orient Tech get SEBI nod to launch IPO
All these four companies filed their DRHP with the SEBI in February this year, while observations came between June 29 and July 2, 2024.
All these four companies filed their DRHP with the SEBI in February this year, while observations came between June 29 and July 2, 2024.
Vraj Iron's public issue worth ₹171 crore comprised only fresh issue of 1,710 million shares; IPO was subscribed to 119.04 times
Stanley Lifestyles receives bids for 98.3 crore shares against 1.02 cr on offer on final day; ABD opens on a good note as bids placed for 1.9 cr shares against 3.9 cr on offer
The Haryana-based piping solutions company looks to raise ₹418 crore at the upper end of the IPO price band.
Issue receives strong interest from non-institutional investors, with quota subscribing 11.72 times
QIBs lead from the front as the quota subscribed 48 times after 109 cr shares were bid for against 2.25 cr on offer
A total of 97 anchor investors take part in the anchor book; they have been allocated 3.37 cr shares at ₹570 apiece
The IPO is a mix of fresh issue of shares up to ₹1,250 crore and an offer for sale (OFS) of up to ₹5,750 crore by Goswami Infratech Private Limited.
P N Gadgil Jewellers looks to raise up to ₹1,100 crore via the IPO route, while Crizac plans to garner up to ₹1,000 crore from the public issue.
Among main board IPOs, the public issue of ₹4,326 crore by Mankind Pharma was the largest in FY24, followed by Tata Tech (₹3,043 cr) and JSW Infra (₹2,800 cr).